Biocorp Production designs, develops, and manufactures medical devices in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; Sween, a device that provides real assistance in the administration of medication and closure systems. The company was incorporated in 2004 and is headquartered in Issoire, France. As of August 4, 2023, Biocorp Production operates as a subsidiary of Novo Nordisk A/S.
Frequently asked questions
What sector does Biocorp Production SA (ALCOR) operate in?
Biocorp Production SA belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Biocorp Production SA (ALCOR) current stock price?
As of the latest data, Biocorp Production SA stock price is €22.50, with a previous close of €23.20. Biocorp Production SA lost -€0.70 in the last trading session, representing a -3.02% loss.
What is Biocorp Production SA (ALCOR) current market capitalization?
Biocorp Production SA market cap is approximately 99.06 million.
What is Biocorp Production SA (ALCOR) Earnings Per Share (EPS)?
The trailing EPS is -€0.15, and the forward EPS is €0.36.
Does Biocorp Production SA (ALCOR) pay dividends?
No. Biocorp Production SA does not pay a dividend.
What is Biocorp Production SA (ALCOR) beta (volatility) score?
Biocorp Production SA has a beta of 0.965, meaning its volatility is roughly in line with the market.
